Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

21 Results

Guidelines and Advice

Clinical Verification of Cancer Drug Prescriptions Checklist: Cancer Centres and Specialty Pharmacies

Status: Current
ID: GL-C50-18

Jan 2015

Guidelines and Advice

Complex Malignant Hematology Models of Care: Recommendations for Changes in the Roles and Composition of the Multidisciplinary Team and the Setting of Care to Improve Access for Patients in Ontario – March 2017

Status: Current
ID: GL-C50-31

Mar 2017

Guidelines and Advice

Consensus Pathology Recommendations for Complex Malignant Hematology – December 2016

Status: Current
ID: GL-C50-28

Dec 2016

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: Current
ID: GL-END 3-21

Jan 2018

Guidelines and Advice

Cancer Care Ontario Beyond-Use Date Recommendations Report

Status: Current
ID: N/A
Version: 1

Mar 2018

Guidelines and Advice

Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum

Status: Current
ID: GL 3-20
Version: N/A

Aug 2019

Guidelines and Advice

Cannabis and cannabinoids: Cancer risk and use to manage cancer symptoms

Status: Current
ID: N/A
Version: 2

Jan 2023

Guidelines and Advice

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-18
Version: N/A

Sep 2020

Guidelines and Advice

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

Status: Current
ID: GL 21-6

Apr 2023

Pages